Guidelines for Transrectal Ultrasonography-Guided Prostate Biopsy: Korean Society of Urogenital Radiology Consensus Statement for Patient Preparation, Standard Technique, and Biopsy-Related Pain Management

• Published in: Korean Journal of Radiology Vol. 21; no. 4; pp. 422 - 430
• Main Authors: Lee, Myoung Seok, Moon, Min Hoan, Kim, Chan Kyo, Park, Sung Yoon, Choi, Moon Hyung, Jung, Sung Il
• Format: Journal Article
• Language: English
• Published: Korea (South) XMLink 01.04.2020; The Korean Society of Radiology; 대한영상의학회
• Subjects: Agreements; Analgesics, Opioid; Anti-Infective Agents; Antibiotics; Anticoagulants; Aspirin; Biopsy; Disease prevention; Drug dosages; Enema; Genitourinary Imaging; Hematuria; Humans; Image-Guided Biopsy; Keywords; Lidocaine; Local anesthesia; Male; Narcotics; Nonsteroidal anti-inflammatory drugs; Pain Management; Patients; Polyethylene glycol; Prostate; Questionnaires; Urology; 방사선과학; Antiplatelet; Periprostatic neurovascular bundle block; Prostate biopsy; Intrarectal lidocaine gel application; Biopsy needle; Local anesthesia; Opioid; Antimicrobial prophylaxis; Anticoagulant; Biopsy core; Enema; Standard technique
• ISSN: 1229-6929; 2005-8330; 2005-8330
• DOI: 10.3348/kjr.2019.0576

The Korean Society of Urogenital Radiology (KSUR) aimed to present a consensus statement for patient preparation, standard technique, and pain management in relation to transrectal ultrasound-guided prostate biopsy (TRUS-Bx) to reduce the variability in TRUS-Bx methodologies and suggest a nationwide guideline. The KSUR guideline development subcommittee constructed questionnaires assessing prebiopsy anticoagulation, the cleansing enema, antimicrobial prophylaxis, local anesthesia methods such as periprostatic neurovascular bundle block (PNB) or intrarectal lidocaine gel application (IRLA), opioid usage, and the number of biopsy cores and length and diameter of the biopsy needle. The survey was conducted using an Internet-based platform, and responses were solicited from the 90 members registered on the KSUR mailing list as of 2018. A comprehensive search of relevant literature from Medline database was conducted. The strength of each recommendation was graded on the basis of the level of evidence. Among the 90 registered members, 29 doctors (32.2%) responded to this online survey. Most KSUR members stopped anticoagulants (100%) and antiplatelets (76%) one week before the procedure. All respondents performed a cleansing enema before TRUS-Bx. Approximately 86% of respondents administered prophylactic antibiotics before TRUS-Bx. The most frequently used antibiotics were third-generation cephalosporins. PNB was the most widely used pain control method, followed by a combination of PNB plus IRLA. Opioids were rarely used (6.8%), and they were used only as an adjunctive pain management approach during TRUS-Bx. The KSUR members mainly chose the 12-core biopsy method (89.7%) and 18G 16-mm or 22-mm (96.5%) needles. The KSUR recommends the 12-core biopsy scheme with PNB with or without IRLA as the standard protocol for TRUS-Bx. Anticoagulants and antiplatelet agents should be discontinued at least 5 days prior to the procedure, and antibiotic prophylaxis is highly recommended to prevent infectious complications. Glycerin cleansing enemas and administration of opioid analogues before the procedure could be helpful in some situations. The choice of biopsy needle is dependent on the practitioners' situation and preferences.